AMA Publishing Group: Neuro-oncology Topic Collection
//www.igerbera.com
en-us
Thu, 22 Dec 2022 00:00:00 GMT
Thu, 22 Dec 2022 12:19:32 GMT
Silverchair
jamams@jamanetwork.org
support@www.igerbera.com
-
Oral β-Glucan and Antibody Response to Ganglioside Vaccine in High-risk Neuroblastoma
//www.igerbera.com/journals/jamaoncology/fullarticle/2799614
Thu, 22 Dec 2022 00:00:00 GMT
This phase 2 randomized clinical trial evaluates the effect of β-glucan administered during vaccine priming on antibody titer and seroconversion rates at a large cancer center in children with high-risk neuroblastoma.
10.1001/jamaoncol.2022.5999
2799614
-
Tucatinib vs安慰剂ERBB2-Positive乳房cer With Brain Metastases
//www.igerbera.com/journals/jamaoncology/fullarticle/2799133
Thu, 01 Dec 2022 00:00:00 GMT
This subgroup analysis of a randomized clinical trial investigates whether tucatinib in combination with trastuzumab and capecitabine provides survival and intracranial benefits for patients with ERBB2-positive metastatic breast cancer and brain metastases.
10.1001/jamaoncol.2022.5610
2799133
-
Cognitive Function and QOL After Resection Followed by WBRT or SRS
//www.igerbera.com/journals/jamaoncology/fullarticle/2797726
Thu, 01 Dec 2022 00:00:00 GMT
This secondary analysis examines the long-term association of whole-brain radiotherapy and stereotactic radiosurgery with quality of life and cognition outcomes for patients with limited brain metastasis following surgical resection.
8
12
1809
1815
10.1001/jamaoncol.2022.5049
2797726
-
Anti-LGI1–Associated Myopathy in the Setting of Neuromuscular Hyperexcitability Syndrome
//www.igerbera.com/journals/jamaneurology/fullarticle/2797276
Thu, 01 Dec 2022 00:00:00 GMT
This case report describes a patient with anti–leucine-rich glioma-inactivated 1 (LGI1)–associated hyperexcitability syndrome associated with myopathy.
79
12
1319
1320
10.1001/jamaneurol.2022.3479
2797276
-
Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer
//www.igerbera.com/journals/jamaoncology/fullarticle/2797265
Thu, 01 Dec 2022 00:00:00 GMT
This case-control study evaluates meningioma risk following radiotherapy and chemotherapy and identifies possible factors associated with modifying radiation-associated risk in survivors of childhood cancer.
8
12
1756
1764
10.1001/jamaoncol.2022.4425
2797265